Viewing StudyNCT02097810

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 2:39 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02097810
Status: COMPLETED
Last Update Posted: 2021-06-09
First Post: 2014-03-21
Brief Title: Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1 NTRK2 NTRK3 ROS1 or ALK Molecular Alterations
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Solid Tumors
Locally Advanced Solid Tumors
Keywords: